House Import Bill Shifts Burden To FDA; Rep. Dingell Opposes, Citing PDMA
Executive Summary
The House-passed "Drug Importation Fairness Act" will place "unrealistic burdens" on FDA, Rep. Klink (D-Penn.) maintained during floor debate June 28.
You may also be interested in...
Pfizer Has New Michigan Representative: Dingell Wins House Primary
Energy & Commerce Committee Ranking Democrat John Dingell is likely to return to Washington in 2003 with Pfizer as a constituent following his victory in the Aug. 6 Michigan primaries
Pfizer Has New Michigan Representative: Dingell Wins House Primary
Energy & Commerce Committee Ranking Democrat John Dingell is likely to return to Washington in 2003 with Pfizer as a constituent following his victory in the Aug. 6 Michigan primaries
FDA Personal Use Drug Import Policy Being Examined By Reps. Tauzin, Dingell
The House Energy & Commerce Committee wants FDA, the Customs Service and the Drug Enforcement Administration to provide a list of all controlled substances brought into the U.S. under FDA's "personal use" exemption import policy.